Wellington Biomedical Innovation Master Investors (Cayman) I L.P. — SEC Form 4 filings

SEC reporting owner CIK 1787092. 3 Form 4 filings on record with FilingPulse; latest filed 2024-09-18.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-04-02 to 2024-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Zenas BioPharma, Inc. (ZBIO)10% owner16
Boundless Bio, Inc. (BOLD)10% owner14
Artiva Biotherapeutics, Inc. (ARTV)10% owner13

Form 4 filings — Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

FiledFormIssuerReported transactionsSource
2024-09-184Zenas BioPharma, Inc. (ZBIO)Conversion (C): 180,635 · Conversion (C): 420,271 · Conversion (C): 200,718 · Conversion (C): 1,568,480 (derivative) · Conversion (C): 3,649,263 (derivative) · Conversion (C): 1,742,858 (derivative)EDGAR
2024-07-224Artiva Biotherapeutics, Inc. (ARTV)Conversion (C): 145,089 · Other (J): 49,019 @ $10.20 · Conversion (C): 145,089 (derivative)EDGAR
2024-04-024Boundless Bio, Inc. (BOLD)Conversion (C): 189,933 · Conversion (C): 366,300 · Conversion (C): 3,703,704 (derivative) @ $0 · Conversion (C): 7,142,857 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1787092 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →